See ProMedix on crunchbase, pitchbook, and gust for more information.
mHUB is a leading independent hardtech and manufacturing innovation center that is focused on creating cutting edge technologies. ProMedix was accepted as a member of the first MedTech chohort in the competitive mHUB incubation accelerator. With the backing of Baxter and Edwards-Elmhurst Life Sciences, they have been a valuable contribution to the ProMedix ecosystem and have provided priceless guidance and knowledge.
The OBI mission is to translate scientific research developed in Oregon’s research laboratories into commercial ventures. We are a member of their organization and house our headquarters here.
Matter is a healthcare incubator that provides startups with various resources designed for business growth. They have been a valuable team member and have provided integral resources and connections that directly promoted the growth of ProMedix.
Ideaship is a patent leveraged venture capital firm that provides patent development support for early-stage startups. They were brought on as an investor to help develop our patent portfolio. They continue to act as a trusted advisor and team member.
Innovation Dupage is a nonprofit venture that unites startup founders with people, resources, and programs that support their growth. We have been an active member of their venture and have been connected with the some of the nation's leading healthcare professionals through them.
CTIP, Consortium for Technology and Innovation in Pediatrics, an FDA pediatric device consortium, chose ProMedix over 90 other companies to receive their grant. Our device represents the only product on the market that can assess sepsis and sepsis resuscitation in a non invasive manner, which CTIP recognized was particularly important for pediatrics. CTIP continues to be a supporter of ProMedix and our research into pediatric sepsis.
ProMedix is an OHSU startup that was cofounded and developed by two OHSU faculty. Our company has received multiple grants from them and continues to have extensive relations with the Technology Transfer Offices and Clinical Research Services.
Elevate Capital is Oregon’s first institutional venture capital fund that specifically targets investments in underserved entrepreneurs. They have been a valuable investor since the beginning, seeing the value in our novel medical device. They continue to be an active supporter of our endeavors, and we are thankful to be connected with a fund that is actively dissolving investment barriers in Oregon.